Yale researchers identified an underactive mTOR pathway as a cause of lissencephaly and reversed brain malformations in ...

Yale researchers discovered that an underactive mTOR pathway drives structural malformations in lissencephaly. They showed ...

Their findings pointed to dysregulation in the mTOR (mammalian target of rapamycin) pathway in both types of lissencephaly ...

Researchers have identified a molecular mechanism driving the structural abnormalities leading to lissencephaly that have ...

By the age of 35, fertility rates drop significantly, with only about 66% of women able to conceive. As women approach ...

Lithium has traditionally been used to treat bipolar disorder and depression. However, researchers at the Center for Synaptic ...

Lithium, a drug widely used for bipolar disorder, may also treat autism spectrum disorder (ASD), according to new research.

A groundbreaking discovery has highlighted lithium-;a drug long used to treat bipolar disorder and depression-;as a potential therapy for autism spectrum disorder (ASD).

SEOUL, Dec. 24 (Korea Bizwire) — Scientists have discovered that lithium, a key component in electric vehicle batteries, ...

Kazia Therapeutics ( (KZIA) ) has provided an announcement.

Kazia Therapeutics Limited (NASDAQ: KZIA), an oncology-focused drug development company, today provided a regulatory update on paxalisib for the treatment of glioblastoma (GBM) following its Type C ...

Lissencephaly is a spectrum of rare, genetic disorders in which the brain fails to develop its hallmark folds. The disorders are often associated with seizures and intellectual disability and ...